| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 May 2025 | 23 May 2025 |
| SMS Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve Audited Financial Results for the fourth quarter and year ended 2025. Approval of Financial results for the fourth quarter and year ended 31st March, 2025. (As per BSE Announcement Dated on 30/05/2025) | ||
| Board Meeting | 27 Mar 2025 | 27 Mar 2025 |
| Allotment of Equity shares pursuant to conversion of warrants. | ||
| Board Meeting | 12 Feb 2025 | 5 Feb 2025 |
| Quarterly Results SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve Financial Results for the quarter ended 31st December, 2024 Outcome of the Board Meeting and Financial Results for the quarter ended 31.12.2024 Submission of updated Code for Regulation and Prohibition of Insider Trading. (As Per BSE Announcement Dated on: 12/02/2025) | ||
| Board Meeting | 8 Nov 2024 | 1 Nov 2024 |
| SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2024 inter alia to consider and approve financial results for the quarter and half year ended 30th September 2024. Outcome of the Board Meeting and Financial Results (As Per BSE Announcement Dated on: 08/11/2024) | ||
| Board Meeting | 5 Aug 2024 | 29 Jul 2024 |
| SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 inter alia to consider and approve Intimation of Board Meeting SMS PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2024 ,inter alia, to consider and approve Update on board meeting - Change in venue of Board Meeting Read less.. (As Per BSE Announcement Dated on 02.08.2024) Outcome of Board Meeting Outcome of Board Meeting and Financial Results for the quarter ended 30th June, 2024. (As per BSE Announcement Dated on 05/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.